Effect of exemestane on the invasive growth of endometrial carcinoma HHUA cells.

CONCLUSION: 6x10⁸ mol/L exemestane is an optimal dose to inhibit the expression of CD44s mRNA and inhibit the invasive growth of the endometrial carcinoma HHUA cells. PMID: 29787009 [PubMed - in process]
Source: European Journal of Gynaecological Oncology - Category: OBGYN Tags: Eur J Gynaecol Oncol Source Type: research